PUBLISHER: Grand View Research | PRODUCT CODE: 1363075
PUBLISHER: Grand View Research | PRODUCT CODE: 1363075
The global blood preparation market size is expected to reach USD 73.59 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 6.4% from 2023 to 2030. The key factors driving the market include growing prevalence of blood-related disorders, extensive usage of its components in several surgical procedures, rising number of transfusion procedures.
Rising number of injuries & accidents, increasing blood donations, and growing government initiatives to raise awareness regarding donation are expected to propel the market during the forecast period. For instance, in November 2022, the World Health Organization/ Pan American Health Organization (PAHO/WHO) with funding support from the United States of America conducted an awareness program by donating promotional items for voluntary donation to save lives in Belize . Moreover, the increasing usage of plasma as life-saving therapeutics for numerous chronic and acute life-threatening diseases such as Hemophilia and Hereditary Angioedema in the biopharmaceutical and pharmaceutical industries is likely to boost the blood preparation market.
The operating players in the market are undertaking numerous strategies such as collaborations, mergers & acquisitions, and product launches. Furthermore, the companies are also focusing on extending their investments on expansion of manufacturing facilities with an aim to meet the demand. For instance, in May 2023, PlasmaGen Biosciences announced an opening of its new facility to boost the production of blood plasma products in India . The facility aims to significantly enhance the supply-demand scenario for products at reasonable prices.
However, the growing incidence of allergic reactions through the transfusion including hypotensive transfusion reactions are anticipated to hamper the market in the study period. In addition, high changes of disease transmission during transfusions such as hepatitis B, HIV and viral hemorrhagic fever may impede the market.
On the other hand, innovations in collection and processing technologies such as automated collection systems, can improve the quality of products by reducing the processing time. For instance, in May 2022, Vitestro, introduced an innovative autonomous blood drawing device. The device is combination of ultrasound-guided 3D reconstruction and artificial intelligence (AI) with robotic needle insertion for secure and precise collection . Thus such initiatives are projected to create lucrative opportunities during the forecast period.